GO_REF:0000002

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including oxidoreductase activity.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000015

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including biological_process.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000033

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including FAD binding; cytochrome-b5 reductase activity, acting on NAD(P)H; mitochondrion.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000044

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including cytoplasm; mitochondrial outer membrane.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000117

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including cytochrome-b5 reductase activity, acting on NAD(P)H.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000120

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including cytochrome-b5 reductase activity, acting on NADH; endoplasmic reticulum membrane.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

GO_REF:0000121

GO reference used by source annotation pipeline

Source annotation pipeline provenance for Cyb5r3 annotations including FAD binding; cytochrome-b5 reductase activity, acting on NAD(P)H; cytochrome-b5 reductase activity, acting on NADH; cytoplasm; cytosol; and 8 other terms.

"GO_REF entry used only to trace source annotation method; biological support was assessed from UniProt and cached literature where available."

PMID:11695905

The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent

For Cyb5r3, this publication provides evidence/provenance for direct annotations to cytochrome-b5 reductase activity, acting on NAD(P)H; cytochrome-b5 reductase activity, acting on NADH and contextual annotations to FAD binding.

"Cytochrome b5 reductase (cb5r) (EC 1.6.6.2) catalyzes the reduction of two molecules of cytochrome b5 using NADH as the physiological electron donor."

PMID:14561759

Proteomic analysis of rat liver peroxisome: presence of peroxisome-specific isozyme of Lon protease

For Cyb5r3, this publication was reviewed as context for endoplasmic reticulum membrane.

"Subcellular proteomics, which includes isolation of subcellular components prior to a proteomic analysis, is advantageous not only in characterizing large macro-molecular complexes such as organelles but also in elucidating mechanisms of protein transport and organelle biosynthesis."

PMID:14609324

The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site

For Cyb5r3, this publication was reviewed as context for ADP binding; AMP binding; NAD binding; flavin adenine dinucleotide binding.

"Methemoglobinemia, the first hereditary disease to be identified that involved an enzyme deficiency, has been ascribed to mutations in the enzyme cytochrome b(5) reductase."

PMID:1577871

A single mRNA, transcribed from an alternative, erythroid-specific, promoter, codes for two non-myristylated forms of NADH-cytochrome b5 reductase

For Cyb5r3, this publication was reviewed as context for cytoplasm.

"Two forms of NADH-cytochrome b5 reductase are produced from one gene: a myristylated membrane-bound enzyme, expressed in all tissues, and a soluble, erythrocyte-specific, isoform."

PMID:2391344

Molecular cloning of a cDNA encoding rat NADH-cytochrome b5 reductase and the corresponding gene

For Cyb5r3, this publication supports direct annotations to cytochrome-b5 reductase activity, acting on NAD(P)H.

"Rat cDNA encoding NADH-cytochrome b5 reductase (b5R) was isolated from a rat liver cDNA library using a human b5R cDNA as a probe."

PMID:8812833

High-level expression in Escherichia coli of the soluble, catalytic domain of rat hepatic cytochrome b5 reductase

For Cyb5r3, this publication provides evidence/provenance for direct annotations to cytochrome-b5 reductase activity, acting on NAD(P)H; cytochrome-b5 reductase activity, acting on NADH and contextual annotations to FAD binding.

"A T7 expression system has been produced for the high-level production of the soluble, catalytic domain of rat hepatic cytochrome b5 reductase in Escherichia coli."

PMID:8978818

A role for N-myristoylation in protein targeting: NADH-cytochrome b5 reductase requires myristic acid for association with outer mitochondrial but not ER membranes

For Cyb5r3, this publication provides evidence/provenance for direct annotations to cytochrome-b5 reductase activity, acting on NAD(P)H; cytochrome-b5 reductase activity, acting on NADH and contextual annotations to endoplasmic reticulum membrane; mitochondrial outer membrane.

"N-myristoylation is a cotranslational modification involved in protein-protein interactions as well as in anchoring polypeptides to phospholipid bilayers; however, its role in targeting proteins to specific subcellular compartments has not been clearly defined."

file:rat/Cyb5r3/Cyb5r3-deep-research-falcon.md

Falcon deep research report on rat Cyb5r3 (NADH-cytochrome b5 reductase 3)

Rat Cyb5r3 (UniProt P20070) corresponds to NADH-cytochrome b5 reductase 3 (EC 1.6.2.2), historically termed diaphorase-1 (DIA1); an FAD-dependent flavoprotein oxidoreductase that uses NADH as the electron donor.

"The rat gene symbol **Cyb5r3** corresponds to **NADH–cytochrome b5 reductase 3** (EC **1.6.2.2**), historically termed **diaphorase-1 (DIA1)** in the methemoglobin reductase literature."
The core redox chemistry is electron transfer from NADH to acceptors such as cytochrome b5 or coenzyme Q (CoQ), producing NAD+.

"A recent 2024 study summarizes the core redox chemistry as **electron transfer from NADH to acceptors such as cytochrome b5 or coenzyme Q (CoQ)**, resulting in **NAD+** production."
CYB5R3 is a prominent one-electron CoQ (ubiquinone) reductase, contrasted with NQO1, which reduces CoQ by a two-electron mechanism; one-electron CoQ chemistry generates semiquinone intermediates.

"A key contemporary framing is that CYB5R3 is a prominent **one-electron CoQ reductase**, contrasted with **NQO1**, which reduces CoQ by a **two-electron** mechanism (avoiding semiquinone formation)."
The membrane-bound isoform localizes to the endoplasmic reticulum, mitochondrial outer membrane (cytosolic face), and plasma membrane; the soluble N-terminally truncated isoform is the principal erythrocyte methemoglobin-reducing system.

"A 2024 review of “free radical reductases” similarly describes CYB5R3 as **membrane-tethered** on **MOM (cytosolic face), ER, and plasma membrane**, positioning it to reduce ferric heme and oxidized CoQ species."
Membrane targeting of CYB5R3 is regulated by N-terminal myristoylation, which influences targeting to the mitochondrial outer membrane versus the ER.

"Membrane targeting includes regulation by **N-terminal myristoylation**, which influences targeting (e.g., MOM vs ER)."
At the ER, membrane-bound Cb5R/CYB5R3 transfers electrons to fatty-acid desaturation/elongation pathways and works in detoxification alongside cytochrome b5 and cytochrome P450 systems.

"At the **ER**, membrane-bound Cb5R/CYB5R3 transfers electrons to pathways including **fatty-acid desaturation/elongation** and works in detoxification alongside **cytochrome b5 and cytochrome P450** systems."
Membrane CYB5R3 participates in lipid/cholesterol metabolism and drug metabolism.

"A 2024 cancer-focused study reiterates participation of membrane CYB5R3 in lipid/cholesterol metabolism and drug metabolism, while emphasizing its broad metabolic involvement."
CYB5R3 maintains the soluble guanylate cyclase (sGC) heme iron in the reduced NO-responsive state, sustaining NO-stimulated cGMP/PKG signaling; loss of CYB5R3 shifts reliance toward sGC activators that act on oxidized/heme-free sGC.

"In a 2023 pulmonary fibrosis model, CYB5R3 is described as maintaining **sGC heme iron redox state**, enabling NO responsiveness and downstream **cGMP/PKG** signaling."
As a membrane free-radical reductase, CYB5R3 maintains reduced CoQ pools that regenerate tocopherol (vitamin E) by reducing tocopheroxyl radicals, thereby suppressing lipid peroxidation (ferroptosis- relevant antioxidant recycling).

"reduced CoQ can regenerate **tocopherol (vitamin E)** by reducing tocopheroxyl radicals, thereby suppressing lipid peroxidation—an organizing concept relevant to ferroptosis sensitivity."
Direct rat genetic/physiology studies of Cyb5r3 in 2023-2024 were not present in the accessible corpus; rat support is strongest for biochemical/membrane evidence (erythrocyte and synaptosomal/plasma membrane contexts) while recent mechanistic/translational updates are primarily mouse/human.

"Direct **rat** genetic/physiology studies of Cyb5r3 in 2023–2024 were not present in the accessible corpus; therefore, recent mechanistic and translational updates are primarily drawn from **mouse/human** systems, while rat support is strongest for biochemical/membrane evidence (erythrocyte and synaptosomal/plasma membrane contexts) and vascular pharmacology discussion."